CytoMed Therapeutics Limited Amortisation Expense
CytoMed Therapeutics Limited (GDTC) reported Amortisation Expense of SGD 29.90 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2026-03-31
| Period end | Amortisation Expense 12 month |
|---|---|
| 2025-12-31 | 29.90K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 12.56K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 2.19K SGD 20-F · filed 2025-04-28 |
| 2022-12-31 | 2.50K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | 2.51K SGD 20-F · filed 2023-05-01 |